The Reply to the letter on the cost-effectiveness of human papillomavirus in Punjab further distorts the scientific record
Cancer
.
2018 Mar 1;124(5):1085.
doi: 10.1002/cncr.31167.
Epub 2017 Nov 22.
Authors
Vivian Suman
1
,
Jacob M Puliyel
1
Affiliation
1
Department of Pediatrics, St. Stephens Hospital, Delhi, India.
PMID:
29165797
DOI:
10.1002/cncr.31167
No abstract available
Publication types
Letter
Comment
MeSH terms
Adolescent
Cost-Benefit Analysis
Female
Humans
Immunization Programs
India
Papillomaviridae*
Papillomavirus Infections*
Papillomavirus Vaccines*
Vaccination
Substances
Papillomavirus Vaccines